An investigation of the factors that regulate muscarinic receptor expression in schizophrenia

Schizophrenia Research

Volumn 158, Issue 1-3, 2014, Pages 247-254

  Seo, Myoung Suk ^a,b   Scarr, Elizabeth ^a,b   Dean, Brian ^a,b  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

CHRM1; Cortex; Human; Post mortem; Schizophrenia; SP1

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; MESSENGER RNA; MICRORNA 107; MUSCARINIC M1 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; PIRENZEPINE; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; 4-DIPHENYLACETOXY-1,1-DIMETHYLPIPERIDINIUM; CHRM1 PROTEIN, HUMAN; CHRM3 PROTEIN, HUMAN; CHRM4 PROTEIN, HUMAN; MUSCARINIC RECEPTOR; PIPERIDINE DERIVATIVE; SP1 PROTEIN, HUMAN; SP3 PROTEIN, HUMAN; TRITIUM;

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM; CHRM1 GENE; CHRM3 GENE; CHRM4 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENE TRANSLOCATION; HUMAN; HUMAN TISSUE; INTRACELLULAR SIGNALING; LIGAND BINDING; MALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; REAL TIME POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING; BRAIN; COHORT ANALYSIS; DIAGNOSTIC USE; METABOLISM; MIDDLE AGED; POLYMERASE CHAIN REACTION; RADIOASSAY;

ADULT; BLOTTING, WESTERN; BRAIN; COHORT STUDIES; HUMANS; MIDDLE AGED; PIPERIDINES; PIRENZEPINE; POLYMERASE CHAIN REACTION; RADIOLIGAND ASSAY; RECEPTORS, MUSCARINIC; RNA, MESSENGER; SCHIZOPHRENIA; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR; TRITIUM;

EID: 84906935073     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.06.039     Document Type: Article

References (32)

1. Anagnostaras S.G., Murphy G.G., Hamilton S.E., Mitchell S.L., Rahnama N.P., Nathanson N.M., Silva A.J. Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice. Nat. Neurosci. 2003, 6(1):51-58.
2. Beveridge N.J., Gardiner E., Carroll A.P., Tooney P.A., Cairns M.J. Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol. Psychiatry 2010, 15(12):1176-1189.
3. Blasi G., Taurisano P., Papazacharias A., Caforio G., Romano R., Lobianco L., Fazio L., Di Giorgio A., Latorre V., Sambataro F., Popolizio T., Nardini M., Mattay V.S., Weinberger D.R., Bertolino A. Nonlinear response of the anterior cingulate and prefrontal cortex in schizophrenia as a function of variable attentional control. Cereb. Cortex 2010, 20(4):837-845.
4. Chuang J.Y., Wang Y.T., Yeh S.H., Liu Y.W., Chang W.C., Hung J.J. Phosphorylation by c-Jun NH2-terminal kinase 1 regulates the stability of transcription factor Sp1 during mitosis. Mol. Biol. Cell 2008, 19(3):1139-1151.
5. Cook R., Weisberg S. Applied Regression Including Computing and Graphics 1999, Wiley, Hoboken.
6. Dean B., Crook J.M., Opeskin K., Hill C., Keks N., Copolov D.L. The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophrenia. Mol. Psychiatry 1996, 1(1):54-58.
7. Dean B., Boer S.A., Mackinnon A., Berk M. CNS 14-3-3zeta: changes with sex but not psychiatric diagnoses or psychotropic drug treatment. Schizophr. Res. 2007, 93(1-3):51-57.
8. Dean B., Soulby A., Evin G.M., Scarr E. Levels of [(3)H]pirenzepine binding in Brodmann's area 6 from subjects with schizophrenia is not associated with changes in the transcription factor SP1 or BACE1. Schizophr. Res. 2008, 106(2-3):229-236.
9. Gibbons A.S., Scarr E., Boer S., Money T., Jeon W.J., Felder C., Dean B. Widespread decreases in cortical muscarinic receptors in a subset of people with schizophrenia. Int. J. Neuropsychopharmacol. 2013, 16(1):37-46.
10. Hill C., Keks N., Roberts S., Opeskin K., Dean B., Copolov D. Diagnostic Instrument for Brain Studies 1999.
11. Jablensky A. Subtyping schizophrenia: implications for genetic research. Mol. Psychiatry 2006, 11(9):815-836.
12. Jeon W.J., Gibbons A.S., Dean B. The use of a modified [3H]4-DAMP radioligand binding assay with increased selectivity for muscarinic M3 receptor shows that cortical CHRM3 levels are not altered in mood disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 47:7-12.
13. Larson E.W., Pfenning M.A., Richelson E. Selectivity of antimuscarinic compounds for muscarinic receptors of human brain and heart. Psychopharmacology 1991, 103(2):162-165.
14. Li L., He S., Sun J.M., Davie J.R. Gene regulation by Sp1 and Sp3. Biochem. Cell Biol. 2004, 82(4):460-471.
15. Mancama D., Arranz M.J., Landau S., Kerwin R. Reduced expression of the muscarinic 1 receptor cortical subtype in schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2003, 119B:2-6.
16. Naghavi H.R., Nyberg L. Common fronto-parietal activity in attention, memory, and consciousness: shared demands on integration?. Conscious. Cogn. 2005, 14(2):390-425.
17. Nathan P.J., Watson J., Lund J., Davies C.H., Peters G., Dodds C.M., Swirski B., Lawrence P., Bentley G.D., O'Neill B.V., Robertson J., Watson S., Jones G.A., Maruff P., Croft R.J., Laruelle M., Bullmore E.T. The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction. Int. J. Neuropsychopharmacol. 2012, 1-11.
18. Pavey G.M., Copolov D.L., Dean B. High-resolution phosphor imaging: validation for use with human brain tissue sections to determine the affinity and density of radioligand binding. J. Neurosci. Methods 2002, 116(2):157-163.
19. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29(9):e45.
20. Raedler T.J., Knable M.B., Jones D.W., Urbina R.A., Gorey J.G., Lee K.S., Egan M.F., Coppola R., Weinberger D.R. In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia. Am. J. Psychiatry 2003, 160(1):118-127.
21. Raedler T.J., Bymaster F.P., Tandon R., Copolov D., Dean B. Towards a muscarinic hypothesis of schizophrenia. Mol. Psychiatry 2007, 12(3):232-246.
22. Ranganath C., Johnson M.K., D'Esposito M. Prefrontal activity associated with working memory and episodic long-term memory. Neuropsychologia 2003, 41(3):378-389.
23. Roberts S.B., Hill C.A., Dean B., Keks N.A., Opeskin K., Copolov D.L. Confirmation of the diagnosis of schizophrenia after death using DSM-IV: a Victorian experience. Aust. NZ J. Psychiatry 1998, 32(1):73-76.
24. Scarr E., Dean B. Muscarinic receptors: do they have a role in the pathology and treatment of schizophrenia?. J. Neurochem. 2008, 107(5):1188-1195.
25. Scarr E., Cowie T.F., Kanellakis S., Sundram S., Pantelis C., Dean B. Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia. Mol. Psychiatry 2009, 14(11):1017-1023.
26. Scarr E., Craig J.M., Cairns M.J., Seo M.S., Galati J.C., Beveridge N.J., Gibbons A., Juzva S., Weinrich B., Parkinson-Bates M., Carroll A.P., Saffery R., Dean B. Decreased cortical muscarinic M1 receptors in schizophrenia are associated with changes in gene promoter methylation, mRNA and gene targeting microRNA. Transl. Psychiatry 2013, 3:e230.
27. Suske G. The Sp-family of transcription factors. Gene 1999, 238(2):291-300.
28. Tan N.Y., Khachigian L.M. Sp1 phosphorylation and its regulation of gene transcription. Mol. Cell. Biol. 2009, 29(10):2483-2488.
29. Udawela M., Scarr E., Hannan A.J., Thomas E.A., Dean B. Phospholipase C beta 1 expression in the dorsolateral prefrontal cortex from patients with schizophrenia at different stages of illness. Aust. NZ J. Psychiatry 2011, 45(2):140-147.
30. Van Wijnen A.J., Bidwell J.P., Fey E.G., Penman S., Lian J.B., Stein J.L., Stein G.S. Nuclear matrix association of multiple sequence-specific DNA binding activities related to SP-1, ATF, CCAAT, C/EBP, OCT-1, and AP-1. Biochemistry 1993, 32(33):8397-8402.
31. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3(7). (RESEARCH0034).
32. Wood I.C., Garriga M., Palmer C.L., Pepitoni S., Buckley N.J. Neuronal expression of the rat M1 muscarinic acetylcholine receptor gene is regulated by elements in the first exon. Biochem. J. 1999, 340(Pt 2):475-483.